SIMRIS GROUP CONFIRMS A TERM EXTENSION TO FLEXIBLE FUNDING FACILITY

Simris Group AB (publ) (“Simris” or the “Company”) requested a maturity term extension of the flexible financing facility that The Brand Laboratories FZ (TBL”), a company associated with Simris’ Chairman, Steven Schapera, provided to the Company on 25 August 2022, and which was subsequently increased on 21 April 2023. TBL has agreed to that request. As such, Simris and TBL have entered into an amended agreement to extend the term of the flexible funding facility provided by TBL. The amended agreement stipulates that the term of the flexible funding facility shall be extended to 31 March 2025. As before, interest will be charged at a rate of 1.0% per month. TBL has made no charge to Simris for this extension.